13.5mg Pemigatinib tablets $150

Pemigatinib is a inhibitor for cholangiocarcinoma that has FGFR2 fusions. It stops FGFR signaling from happening. It comes in three pill sizes: 4.5 mg, 9 mg, or 13.5 mg.

Doctors usually suggest taking the 13.5 mg pill once a day for 14 days out of every 21 days. There are 14 tablets in each bottle. It’s a prescription drug, meant to treat folks who have cholangiocarcinoma that has spread or is worse, and which is caused by FGFR2 fusions.